Antibody responses to immunoevasion proteins BBK32 and OspE constitute part of the serological footprint in neuroborreliosis but are insufficient to prevent the disease
Open Access
- 11 January 2024
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 99 (4) , e13353
Abstract
Lyme borreliosis, caused by Borrelia burgdorferi sensu lato, is the most common tickborne disease. Its neuronal form, neuroborreliosis, comprises 3 to 38% of borreliosis cases in Europe. Borrelia outer surface proteins and virulence factors, OspE and BBK32, have been previously reported to help cause infection by promoting attachment to human host epithelial cells and evading complement attack. We assessed the serological responses to BBK32 and OspE in 19 individuals diagnosed with neuroborreliosis to see whether antibodies that could both target the bacteria and neutralize the virulence mechanisms on the microbial surface emerge. Results evaluate levels of total protein, IgG and the chemokine CXCL13, a determinant for B‐cell recruitment during neuroinflammation, in patients' cerebrospinal fluid samples. Antibody levels against BBK32 and OspE correlated with those against VlsE, a well‐characterized diagnostic serological marker of the disease. A dual serological profile of the patients was observed. K‐means clustering split the cohort into two discrete groups presenting distinct serological and CNS responses. One group contained young patients with low levels of anti‐BBK32 and OspE antibodies. The other group showed stronger responses, possibly following prolonged infections or reinfections. Additionally, we assessed anti‐ganglioside antibodies that could cause autoimmunity or complement dysregulation but observed that they did not correlate with neuroborreliosis in our patient cohort. The dual nature of antibody responses against the virulence factors BBK32 and OspE in neuroborreliosis patients may suggest the necessity of repeated exposures for efficient immune responses. Better protection could be achieved if the virulence factors were formulated into vaccines.Keywords
Funding Information
- Sigrid Juséliuksen Säätiö
- Jane ja Aatos Erkon Säätiö
This publication has 64 references indexed in Scilit:
- Issues in the Diagnosis and Treatment of Lyme DiseaseThe Open Neurology Journal, 2012
- Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetesNature Reviews Microbiology, 2012
- Epidemiology of Lyme Borreliosis2009
- Outer surface protein E antibody response and its effect on complement factor H binding to OspE in Lyme borreliosisMicrobes and Infection, 2008
- Borrelia gariniiInduces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2Infection and Immunity, 2007
- Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosisEuropean Journal of Immunology, 2005
- Immune evasion of Borrelia burgdorferi: mapping of a complement‐inhibitor factor H‐binding site of BbCRASP‐3, a novel member of the Erp protein familyEuropean Journal of Immunology, 2003
- Further Characterization of Complement Regulator-Acquiring Surface Proteins ofBorrelia burgdorferiInfection and Immunity, 2001
- Regulation of OspE-Related, OspF-Related, and Elp Lipoproteins of Borrelia burgdorferi Strain 297 by Mammalian Host-Specific SignalsInfection and Immunity, 2001
- Dermatologic Manifestations of Lyme DiseaseClinical Infectious Diseases, 1989